The 36-month beta value for AWH is at 1.41. Analysts have varying views on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AWH is 21.34M, and currently, shorts hold a 4.55% of that float. The average trading volume for AWH on April 03, 2025 was 4.51M shares.
AWH) stock’s latest price update
Aspira Women’s Health Inc (NASDAQ: AWH) has experienced a rise in its stock price by 10.42 compared to its previous closing price of 0.10. However, the company has seen a gain of 1.92% in its stock price over the last five trading days. accessnewswire.com reported 2025-03-31 that The Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women’s Health Inc. (“Aspira”) (NASDAQ:AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today announced the successful completion of the second development milestone of its Advanced Research Projects Agency for Health (ARPA-H) award. As a result of satisfying the second development milestone, Aspira received a $1.5 million cash payment under the terms of the related $10 million agreement.
AWH’s Market Performance
Aspira Women’s Health Inc (AWH) has experienced a 1.92% rise in stock performance for the past week, with a -30.49% drop in the past month, and a -84.91% drop in the past quarter. The volatility ratio for the week is 11.67%, and the volatility levels for the past 30 days are at 21.98% for AWH. The simple moving average for the past 20 days is -16.17% for AWH’s stock, with a -86.57% simple moving average for the past 200 days.
Analysts’ Opinion of AWH
Many brokerage firms have already submitted their reports for AWH stocks, with Cantor Fitzgerald repeating the rating for AWH by listing it as a “Overweight.” The predicted price for AWH in the upcoming period, according to Cantor Fitzgerald is $4 based on the research report published on January 12, 2022 of the previous year 2022.
Truist, on the other hand, stated in their research note that they expect to see AWH reach a price target of $12. The rating they have provided for AWH stocks is “Buy” according to the report published on March 29th, 2021.
Cantor Fitzgerald gave a rating of “Overweight” to AWH, setting the target price at $10 in the report published on January 29th of the previous year.
AWH Trading at -53.92% from the 50-Day Moving Average
After a stumble in the market that brought AWH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.08% of loss for the given period.
Volatility was left at 21.98%, however, over the last 30 days, the volatility rate increased by 11.67%, as shares sank -35.86% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -77.56% lower at present.
During the last 5 trading sessions, AWH rose by +5.77%, which changed the moving average for the period of 200-days by -94.36% in comparison to the 20-day moving average, which settled at $0.1266. In addition, Aspira Women’s Health Inc saw -84.96% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at AWH starting from Sandford Nicole, who purchase 9,493 shares at the price of $2.42 back on May 31 ’24. After this action, Sandford Nicole now owns 70,596 shares of Aspira Women’s Health Inc, valued at $22,973 using the latest closing price.
Stock Fundamentals for AWH
Current profitability levels for the company are sitting at:
- -1.89 for the present operating margin
- 0.58 for the gross margin
The net margin for Aspira Women’s Health Inc stands at -1.65. The total capital return value is set at 24.02.
Based on Aspira Women’s Health Inc (AWH), the company’s capital structure generated -5.67 points at debt to capital in total, while cash flow to debt ratio is standing at -6.79. The debt to equity ratio resting at -0.85. The interest coverage ratio of the stock is -849.1.
Currently, EBITDA for the company is -16.28 million with net debt to EBITDA at -0.0. When we switch over and look at the enterprise to sales, we see a ratio of 0.35. The receivables turnover for the company is 7.15for trailing twelve months and the total asset turnover is 1.88. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.76.
Conclusion
In conclusion, Aspira Women’s Health Inc (AWH) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
